Chenming Zeng
Impact in
- Aging top 10%
- Cell Biology top 10%
- Aldose Reductase and Taurine
- Hippo pathway signaling and YAP/TAZ
Papers in
-
- CRISPR and Genetic Engineering 5
- Ubiquitin and proteasome pathways 4
- RNA Research and Splicing 3
- RNA modifications and cancer 3
-
- Aldose Reductase and Taurine 5
- Co-authors
- Qiaojun He (16 shared papers)Bo Yang (13 shared papers)Hong Zhu (13 shared papers)Ji Cao (5 shared papers)Meidan Ying (5 shared papers)Xiaoyang Dai (5 shared papers)Chenxi Zhao (4 shared papers)Fangjie Yan (5 shared papers)
- Journals
- Nature Communications (5 papers)Acta Pharmacologica Sinica (3 papers)Cell Reports (2 papers)Theranostics (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited KingdomGermany
In The Last Decade
Chenming Zeng
23 papers receiving 472 citations
Peers
Comparison fields: 5 of 69
- Aging 32
- Cell Biology 133
- Cancer Research 68
- Geriatrics and Gerontology 15
- Molecular Biology 283
Countries citing papers authored by Chenming Zeng
This map shows the geographic impact of Chenming Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenming Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenming Zeng more than expected).
Fields of papers citing papers by Chenming Zeng
This network shows the impact of papers produced by Chenming Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenming Zeng. The network helps show where Chenming Zeng may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenming Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 104 | |
| 2 | 2017 | 72 | |
| 3 | 2018 | 37 | |
| 4 | 2019 | 36 | |
| 5 | 2018 | 31 | |
| 6 | 2020 | 27 | |
| 7 | 2019 | 25 | |
| 8 | 2020 | 18 | |
| 9 | 2024 | 16 | |
| 10 | 2020 | 16 | |
| 11 | 2024 | 14 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 14 | |
| 14 | 2019 | 14 | |
| 15 | 2023 | 11 | |
| 16 | 2021 | 8 | |
| 17 | 2021 | 4 | |
| 18 | 2025 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2024 | 2 |
About Chenming Zeng
Chenming Zeng is a scholar working on Molecular Biology, Cell Biology, Plant Science, Cancer Research and Aging, having authored 26 papers that have together received 474 indexed citations. Recurring topics across this work include Aldose Reductase and Taurine (5 papers), CRISPR and Genetic Engineering (5 papers), Ubiquitin and proteasome pathways (4 papers), Genetics, Aging, and Longevity in Model Organisms (4 papers), Chromosomal and Genetic Variations (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), RNA Research and Splicing (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Aging (32 citations), Cell Biology (133 citations), Cancer Research (68 citations), Geriatrics and Gerontology (15 citations) and Molecular Biology (283 citations). Chenming Zeng has collaborated with scholars based in China, United Kingdom and Germany. Frequent co-authors include Qiaojun He, Bo Yang, Hong Zhu, Ji Cao, Meidan Ying, Xiaoyang Dai, Chenxi Zhao, Fangjie Yan, Tao Yuan and Yan Hu. Their work appears in journals such as Nature Communications, Acta Pharmacologica Sinica, Cell Reports, Theranostics and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.